The Latin America, Middle East and Africa Clinical Decision Support Systems Market is expected to witness market growth of 15.2% CAGR during the forecast period (2021-2027).
The introduction of CDSS as a supportive tool can help healthcare entities overcome the challenges of making high-quality clinical decisions. CDSS has been recognized as a critical instrument for overcoming challenges in providing high-quality treatment to patients by enhancing and streamlining healthcare delivery.
The enforcement of government restrictions and efforts to encourage the deployment of HIT solutions, rising adoption of CDSS-enabled EHRs, the growing number of collaborations and partnerships between stakeholders, rising incidence of medication errors, and the rising prominence of mHealth and big data tools are the key factors propelling the growth of this market. However, the high costs of implementing CDSS, as well as a lack of interoperability and data security concerns, are projected to limit the market's growth throughout the forecasting period.
LAMEA is a lucrative hub for the clinical decision support systems market. The healthcare infrastructure of countries that lies in LAMEA is weaker when compared to other regions. In addition, a substantial number of deaths that are being caused by multiple diseases make the region highly conducive for the demand and growth of equipment that comprises the ability to strengthen the healthcare services in countries across the region.
The Brazil market dominated the LAMEA Clinical Decision Support Systems Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $151.1 million by 2027. The Argentina market is expected to exhibit a CAGR of 15.8% during (2021 - 2027). Additionally, The UAE market is poised to grow a CAGR of 14.9% during (2021 - 2027).
Based on Component, the market is segmented into Services, Hardware, and Software. Based on Product, the market is segmented into Standalone CDSS, Integrated CDSS with CPOE & E.H.R., Integrated E.H.R. with CDSS, and Others. Based on Delivery Mode, the market is segmented into On-premise Systems, Web-based Systems, and Cloud-based Systems. Based on Application, the market is segmented into Drug Allergy Alerts, Drug-drug Interactions, Clinical Guidelines, Drug Dosing Support, Clinical Reminders, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), AllScripts Healthcare Solutions, Inc., General Electric (GE) Co. (GE Healthcare), NextGen Healthcare, Inc., Athenahealth, Inc. (Veritas Capital), Epic Systems Corporation, eClinicalWorks LLC, Change Healthcare, Inc., and Zynx Health, Inc. (Hearst Communications, Inc.).
The introduction of CDSS as a supportive tool can help healthcare entities overcome the challenges of making high-quality clinical decisions. CDSS has been recognized as a critical instrument for overcoming challenges in providing high-quality treatment to patients by enhancing and streamlining healthcare delivery.
The enforcement of government restrictions and efforts to encourage the deployment of HIT solutions, rising adoption of CDSS-enabled EHRs, the growing number of collaborations and partnerships between stakeholders, rising incidence of medication errors, and the rising prominence of mHealth and big data tools are the key factors propelling the growth of this market. However, the high costs of implementing CDSS, as well as a lack of interoperability and data security concerns, are projected to limit the market's growth throughout the forecasting period.
LAMEA is a lucrative hub for the clinical decision support systems market. The healthcare infrastructure of countries that lies in LAMEA is weaker when compared to other regions. In addition, a substantial number of deaths that are being caused by multiple diseases make the region highly conducive for the demand and growth of equipment that comprises the ability to strengthen the healthcare services in countries across the region.
The Brazil market dominated the LAMEA Clinical Decision Support Systems Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $151.1 million by 2027. The Argentina market is expected to exhibit a CAGR of 15.8% during (2021 - 2027). Additionally, The UAE market is poised to grow a CAGR of 14.9% during (2021 - 2027).
Based on Component, the market is segmented into Services, Hardware, and Software. Based on Product, the market is segmented into Standalone CDSS, Integrated CDSS with CPOE & E.H.R., Integrated E.H.R. with CDSS, and Others. Based on Delivery Mode, the market is segmented into On-premise Systems, Web-based Systems, and Cloud-based Systems. Based on Application, the market is segmented into Drug Allergy Alerts, Drug-drug Interactions, Clinical Guidelines, Drug Dosing Support, Clinical Reminders, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), AllScripts Healthcare Solutions, Inc., General Electric (GE) Co. (GE Healthcare), NextGen Healthcare, Inc., Athenahealth, Inc. (Veritas Capital), Epic Systems Corporation, eClinicalWorks LLC, Change Healthcare, Inc., and Zynx Health, Inc. (Hearst Communications, Inc.).
Scope of the Study
Market Segments Covered in the Report:
By Component
- Services
- Hardware
- Software
By Product
- Standalone CDSS
- Integrated CDSS with CPOE & E.H.R.
- Integrated E.H.R. with CDSS
- Others
By Delivery Mode
- On-premise Systems
- Web-based Systems
- Cloud-based Systems
By Application
- Drug Allergy Alerts
- Drug-drug Interactions
- Clinical Guidelines
- Drug Dosing Support
- Clinical Reminders
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Siemens Healthineers AG (Siemens AG)
- Cerner Corporation (Oracle Corporation)
- AllScripts Healthcare Solutions, Inc.
- General Electric (GE) Co. (GE Healthcare)
- NextGen Healthcare, Inc.
- Athenahealth, Inc. (Veritas Capital)
- Epic Systems Corporation
- eClinicalWorks LLC
- Change Healthcare, Inc.
- Zynx Health, Inc. (Hearst Communications, Inc.)
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Clinical Decision Support Systems Market by Component
Chapter 5. LAMEA Clinical Decision Support Systems Market by Product
Chapter 6. LAMEA Clinical Decision Support Systems Market by Delivery Mode
Chapter 7. LAMEA Clinical Decision Support Systems Market by Application
Chapter 8. LAMEA Clinical Decision Support Systems Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Siemens Healthineers AG (Siemens AG)
- Cerner Corporation (Oracle Corporation)
- AllScripts Healthcare Solutions, Inc.
- General Electric (GE) Co. (GE Healthcare)
- NextGen Healthcare, Inc.
- Athenahealth, Inc. (Veritas Capital)
- Epic Systems Corporation
- eClinicalWorks LLC
- Change Healthcare, Inc.
- Zynx Health, Inc. (Hearst Communications, Inc.)
Methodology
LOADING...
